You can buy or sell GSK and other stocks, options, and ETFs commission-free!
GlaxoSmithKline plc, also called GlaxoSmithKline, is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom. The listed name for GSK is GlaxoSmithKline plc.
Emma N. Walmsley
Middlesex, Greater London
52 Week High
52 Week Low
Vectura's $89.7 mln inhaler patent win against GSK upheld
GlaxoSmithKline PLC has lost an appeal seeking to overturn an $89.7 million verdict a jury handed down after finding that the company’s Ellipta line of inhalers
Jon Najarian Says These 2 Vaccine Manufacturers Haven't Been Talked About Enough
On CNBC's "Fast Money Halftime Report," Jon Najarian discussed the current state of vaccines and said some companies haven't been getting enough attention. The
— per share
Available Feb 3